Skip to main content
KUKJEON PHARMACEUTICAL Co.,Ltd logo

KUKJEON PHARMACEUTICAL Co.,Ltd — Investor Relations & Filings

Ticker · 307750 ISIN · KR7307750000 KO Manufacturing
Open in API
Filings indexed 323 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 307750

About KUKJEON PHARMACEUTICAL Co.,Ltd

https://www.kukjeon.co.kr/en/

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company's portfolio includes raw materials for specialized medicines such as choline alfoscerates, benfothiamines, and napamostat. A key product is Itopride hydrochloride, a functional indigestion treatment, for which the company holds a proprietary manufacturing patent. In addition to its pharmaceutical focus, the company also develops and supplies chemical materials for the electronics industry.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) for the period January 1, 2026 to March 31, 2026, filed with the Financial Services Commission and the Korea Exchange. It contains detailed financial statements, business overview, capital changes, and other comprehensive interim period disclosures. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a Korean ‘주식등의 대량보유상황보고서’ (Large Shareholding Report) filed with the Financial Services Commission and Korea Exchange. It details the number and percentage of shares held by the reporting person and their related parties, changes in holdings, contract details (pledges, borrowings), and reasons for the report (e.g., repayment of stock‐secured loan). This matches a Major Shareholding Notification rather than a financial report, earnings release, or management announcement.
2026-05-12 Korean
주식등의대량보유상황보고서(약식)
Regulatory Filings
2026-05-07 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a brief announcement about a change in the company's listing segment from '우량기업부' (Excellent Enterprise Division) to '중견기업부' (Mid-sized Enterprise Division) effective on 2026-05-04. It is very short (228 characters) and contains no financial data, no report, no management or board changes, no voting results, no legal or financing information. It is a regulatory announcement about a change in the company's listing or classification on the exchange. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2026-04-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a “주식등의 대량보유상황보고서” (Large Shareholding Status Report) filed under Korea’s Capital Markets Act, detailing a major shareholder’s holdings, threshold crossings, related contracts, and beneficiary information. This is not an earnings release or management discussion but a notification of significant changes in share ownership levels. Accordingly, it fits the definition of a Major Shareholding Notification.
2026-04-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a formal report titled “주식등의 대량보유상황보고서(일반)” under the Korean Capital Markets Act, detailing large shareholding (>5%) by 홍종호 and related parties, including share counts, ratios, changes, and contract details. It is clearly a major shareholding notification rather than an earnings release, AGM material, or management commentary. Therefore, it matches the “Major Shareholding Notification” category (Code: MRQ).
2026-04-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.